Scout | PAR-23-069: Commercialization Readiness Pilot (CRP) Program: Technical Assistance and Late Stage Development (SB1 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant PAR-23-069

Commercialization Readiness Pilot (CRP) Program: Technical Assistance and Late Stage Development (SB1 Clinical Trial Not Allowed)

Summary

This grant opportunity aims to help small businesses enhance their leadership teams by adding entrepreneurial expertise. It also supports activities that foster partnerships to boost commercialization efforts through private funding or industry collaborations. Note that clinical trials are not eligible for this grant.

This FOA supports the addition of entrepreneurial expertise into small business leadership teams along with supporting partnering activities to aid in commercialization through private third-party funding or partnership with industry. Clinical trials are not accepted under this FOA.

Funding Source

Agency: National Institutes of Health

Sub-agency: National Institute of Neurological Disorders and Stroke

Phase: Phase II

Phase: Phase I

Awards & funding

Award Ceiling: $400,000

Award Amount: $400,000

Eligibility

U.S. Small Business Concerns (SBCs) with an NIH SBIR or STTR Phase II or Phase IIB award in pain management (active or ended within the last 36 months)

SBCs owned and controlled (>50%) by U.S. individuals, other U.S.-owned SBCs, Indian Tribes, Alaska Native Corporations (ANCs), or Native Hawaiian Organizations (NHOs) (or their wholly owned entities)

SBIR-only: SBCs majority-owned by multiple venture capital operating companies (VCOCs), hedge funds, and/or private equity firms (no single firm >50% unless itself a qualifying U.S.-owned SBC)

Joint ventures of eligible SBCs that meet SBA ownership/control requirements and foreign-participation limits (<50% participation by foreign business entities in the joint venture)

Core eligibility: Only U.S. Small Business Concerns (SBCs) may apply. Applicants must have an NIH SBIR or STTR Phase II or Phase IIB contract or grant award from a participating NIH Institute/Center that is either: (a) currently active at the requested project start date, or (b) ended within the…

Dates

Application Window Closes: September 5, 2025

Opportunity Released: January 3, 2023

Open for Submission: January 3, 2023

Submission Deadline: September 5, 2025

Supporting links

National Institutes of Health

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers